Finally, acute myeloid leukemia (AML) blasts from 79 consecutive patients cultured in serum-free medium revealed differences in the constitutive release of protease/protease regulators, including Ahsg, that contribute to disease heterogeneity [73]. The gene discussed is AHSG; the disease is acute myeloid leukemia.